Boston Scientific (BSX) Other financing activities (2019 - 2026)

Boston Scientific (BSX) has 8 years of Other financing activities data on file, last reported at $3.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities rose 130.0% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $295.0 million (up 424.18% YoY), and the FY2025 full-year result was $282.0 million, up 28300.0% from the prior year.
• Other financing activities declined to $3.0 million in Q1 2026, from $284.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $284.0 million in Q4 2025 to a low of -$242.0 million in Q4 2023.
• A 5-year average of $20.2 million and a median of $26.0 million in 2024 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities sank 1373.68% in 2023 and soared 9366.67% in 2025, its largest moves.
• Tracing BSX's Other financing activities over 5 years: stood at $19.0 million in 2022, then slumped by 1373.68% to -$242.0 million in 2023, then soared by 101.24% to $3.0 million in 2024, then soared by 9366.67% to $284.0 million in 2025, then sank by 98.94% to $3.0 million in 2026.
• Business Quant data shows BSX's Other financing activities at $3.0 million in Q1 2026, $284.0 million in Q4 2025, and -$149.0 million in Q3 2025.